Tag: CX 2022
Five-year data presented at Charing Cross reinforce safety of Passeo-18 Lux...
New long-term data presented at Charing Cross (CX) demonstrated the safety of BIOTRONIK’s Passeo-18 Lux paclitaxel drug-coated balloon (DCB) for the treatment of peripheral...
CX 2022: A conversation with Robert Hinchliffe
Robert Hinchliffe (University of Bristol, Bristol, UK) shares his excitement to attend the upcoming CX Symposium (26–28 April, London, UK). “CX has always represented...
CX returns to in-person format once more in the London spring
Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to this year's symposium, due to be held 26–28 April in London, UK, and...
